Advertisement
Advertisement

ELTX

ELTX logo

Elicio Therapeutics Inc.

5.08
USD
-0.074
-1.44%
Dec 18, 15:59 UTC -5
Closed
...

Elicio Therapeutics Inc. Profile

About

Elicio Therapeutics is a privately-held clinical-stage biotechnology company. It involved in developing a pipeline of novel immunotherapies for the treatment of cancer and other diseases. Elicio Therapeutics, formerly known as Angion Biomedica Corp, is based in BOSTON.

Info & Links

CEO

Robert Connelly

Headquarters

451 D Street, 5th Floor
Boston, MA 02210, UNITED STATES

Industry

Biotechnology

Sector

Health Technology

Website

www.elicio.com

Auditor

Baker Tilly US, LLP

Share holders

245

Employees

32

Elicio Therapeutics Inc. Statistics

Valuation Measures

Market Capitalization2

54.77M

Enterprise Value

47.27M

Enterprise Value/EBITDA(ttm)

-1.19

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-555.45%

Return on Invested Capital(ttm)

-2102.80%

Return on Assets(ttm)

-177.34%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-39.72M

Net Income Available to Common(ttm)

-46.84M

Diluted EPS(ttm)

-6.95

Share Statistics

Beta (5Y Monthly)

0.66

52-Week Change

-22.39%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

10.79M

Dividend Yield

0.00%

Float4

7.70M

% Held by Insiders

28.65%

% Held by Institutions

35.03%

Balance Sheet

Total Cash(mrq)

27.33M

Total Cash Per Share(mrq)

2.53

Total Debt(mrq)

19.84M

Total Debt/Equity(mrq)

-104.47%

Current Ratio(mrq)

3.40%

Quick Ratio(mrq)

3.40%

Book Value Per Share(mrq)

-1.76

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.09

Free Cash Flow(ytd)

-28.36M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement